boronophenylalanine
Small moleculeexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2001 (NCT00115440)
Timeline
2000s
- Jan 1, 2001
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiodepletion
Radiodepletion
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bononophenylalanine
- boronphenylalanine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07058116 | Phase 1 | May 8, 2025 | Neutron Therapeutics, LLC, University of Helsinki |
| NCT01233492 | Phase 1 | Oct 1, 2007 | Cancer Research UK, University of Birmingham |
| NCT00115440 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2001 | Boneca Corporation, University of Helsinki |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Helsinki | Academic/Hospital | 2 | 0 | 2 | 2001 |
| Boneca Corporation | For profit | 1 | 1 | 1 | 2001 |
| Cancer Research UK | Academic/Hospital | 1 | 1 | 1 | 2007 |
| Neutron Therapeutics, LLC | For profit | 1 | 1 | 1 | 2025 |
| University of Birmingham | Academic/Hospital | 1 | 0 | 1 | 2007 |
5 organizations
Page 1 / 1